Terms: = Liver cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Prognosis
5 results:
1. LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy.
Wang H; Zhou Q; Xie DF; Xu Q; Yang T; Wang W
Cell Death Dis; 2024 Feb; 15(2):165. PubMed ID: 38388484
[TBL] [Abstract] [Full Text] [Related]
2. HGF-mediated elevation of etv1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET.
Zhang T; Wang Y; Xie M; Ji X; Luo X; Chen X; Zhang B; Liu D; Feng Y; Sun M; Huang W; Xia L
J Exp Clin Cancer Res; 2022 Sep; 41(1):275. PubMed ID: 36109787
[TBL] [Abstract] [Full Text] [Related]
3. Viral infections and the efficacy of PD-(L)1 inhibitors in virus-related cancers: Head and neck squamous cell carcinoma and hepatocellular carcinoma.
Liu T; Li Q; Lin Z; Wang P; Chen Y; Fu Y; Ding Z
Int Immunopharmacol; 2021 Nov; 100():108128. PubMed ID: 34537483
[TBL] [Abstract] [Full Text] [Related]
4. KIT Exon 11 Codons 557-558 Deletion Mutation Promotes liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors.
Wang HC; Li TY; Chao YJ; Hou YC; Hsueh YS; Hsu KH; Shan YS
Clin Cancer Res; 2016 Jul; 22(14):3477-87. PubMed ID: 26936919
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.
Pidala J; Chai X; Kurland BF; Inamoto Y; Flowers ME; Palmer J; Khera N; Jagasia M; Cutler C; Arora M; Vogelsang G; Lee SJ
Biol Blood Marrow Transplant; 2013 May; 19(5):784-91. PubMed ID: 23395601
[TBL] [Abstract] [Full Text] [Related]
